Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Lamictal Birth Defects

Lamictal May Cause Meningitis, FDA Warns

Aug 12, 2010
| Parker Waichman LLP
Lamictal (lamotrigine), a treatment for seizures and bipolar disorder marketed by GlaxoSmithKline, can cause aseptic meningitis, the US Food &...

Epilepsy Drugs to Carry Suicide Warnings

Dec 17, 2008
| Parker Waichman LLP
Epilepsy drugs must now carry warnings about their suicide risks, the Food & Drug Administration (FDA) has announced.  The drugs subject to...

Epilepsy Drugs Targeted for Black Box Suicide Warning

Jul 8, 2008
| Parker Waichman LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...

New Suicide Warning for Epilepsy Drugs

Jun 12, 2008
| Parker Waichman LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior.  The...

Epilepsy Drugs to Get Suicide Warnings, FDA Confirms

Jun 6, 2008
| Parker Waichman LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today.  This past...

Epilepsy Drugs Double Suicide Risks, FDA Warns

Feb 2, 2008
| Parker Waichman LLP
Epilepsy drugs have been linked to a increased risk of suicidal thoughts and behavior, the Food & Drug Administration (FDA) warned this...

Glaxo bipolar drug may be tied to defect

Sep 29, 2006
| AP
Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to...

Glaxo Bipolar Drug May Be Tied to Defects

Sep 29, 2006
| AP
Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to...

First-Trimester Exposure to Lamictal May Cause Oral Cleft

Sep 29, 2006
| Medscape
The US Food and Drug Administration (FDA) has notified healthcare professionals regarding new preliminary information from the North American...

Company notes association between anti-epileptic drug, cleft palate in babies

Aug 9, 2006
| Canadian Press
Drugmaker GlaxoSmithKline is informing pregnant women of a possible association between an anti-epileptic medication and cleft palate or cleft lip in...

Page 1/1

Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo Protected by Copyscape Web Copyright Protection Software php-5 VendorsBay Inc